{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:9739"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:9739","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Oesophagectomy as a model of the Acute Respiratory Distress Syndrome","abstract":"Acute Respiratory Distress Syndrome (ARDS) is a life­threatening illness which can follow major surgery, including oesophagectomy. This thesis aimed to confirm the importance of ARDS in this cohort and assess the effects of GSK2862277 Methods Analysis of previous oesophagectomy trials modelling ARDS sought differences between the studies and identified risk factors. The immunomodulatory effects of oesophagectomy and critical illness and novel therapeutic GSK2862277 on macrophage and neutrophil function were investigated using in vitro assays. Results Previous trials showed the harm to patients associated with ARDS, but falling ARDS rates more recently. Active smoking and pre-­operative dihydropyridine use were risk factors for ARDS. Oesophagectomy and critical illness modulate neutrophil extracellular trap formation but not phagocytosis. GSK2862277 appears to cause an off-­target effect increasing neutrophil extracellular trap formation. GSK2862277 increases alveolar macrophage phagocytosis. Discussion Perioperative ARDS has decreased following oesophagectomy although it is harmful to patients who develop it. Oesophagectomy is no longer useful as a model of ARDS. Major surgery and critical illness effect neutrophil function, which may drive complications in these cohorts. Macrophage function was modulated by GSK2862277, suggesting it may have promise in future for preventing or treating ARDS and other post-­operative pulmonary complications.","abstract_html":"Acute Respiratory Distress Syndrome (ARDS) is a life­threatening illness which can follow major surgery, including oesophagectomy. This thesis aimed to confirm the importance of ARDS in this cohort and assess the effects of GSK2862277 Methods Analysis of previous oesophagectomy trials modelling ARDS sought differences between the studies and identified risk factors. The immunomodulatory effects of oesophagectomy and critical illness and novel therapeutic GSK2862277 on macrophage and neutrophil function were investigated using in vitro assays. Results Previous trials showed the harm to patients associated with ARDS, but falling ARDS rates more recently. Active smoking and pre-­operative dihydropyridine use were risk factors for ARDS. Oesophagectomy and critical illness modulate neutrophil extracellular trap formation but not phagocytosis. GSK2862277 appears to cause an off-­target effect increasing neutrophil extracellular trap formation. GSK2862277 increases alveolar macrophage phagocytosis. Discussion Perioperative ARDS has decreased following oesophagectomy although it is harmful to patients who develop it. Oesophagectomy is no longer useful as a model of ARDS. Major surgery and critical illness effect neutrophil function, which may drive complications in these cohorts. Macrophage function was modulated by GSK2862277, suggesting it may have promise in future for preventing or treating ARDS and other post-­operative pulmonary complications.","abstract_has_math":false,"creators":["Howells, Phillip Alexander"],"institution":"University of Birmingham","degree_name":"d_m_d","degree_level":"d_m_d","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-12","date_published":"2019-12","updated_at":"2026-11-19T09:30:54Z","subjects":["RD Surgery","RM Therapeutics. Pharmacology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/9739/7/Howells2019MD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A9739","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["other"]},{"key":"dc:creator","label":"Author","values":["Howells, Phillip Alexander"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-12-13"]},{"key":"dc:date.issued","label":"Date","values":["2019-12"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Inflammation and Ageing"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/9739/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_m_d"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_m_d"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RD Surgery","RM Therapeutics. Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/9739/7/Howells2019MD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Acute Respiratory Distress Syndrome (ARDS) is a life­threatening illness which can follow major surgery, including oesophagectomy. This thesis aimed to confirm the importance of ARDS in this cohort and assess the effects of GSK2862277 Methods Analysis of previous oesophagectomy trials modelling ARDS sought differences between the studies and identified risk factors. The immunomodulatory effects of oesophagectomy and critical illness and novel therapeutic GSK2862277 on macrophage and neutrophil function were investigated using in vitro assays. Results Previous trials showed the harm to patients associated with ARDS, but falling ARDS rates more recently. Active smoking and pre-­operative dihydropyridine use were risk factors for ARDS. Oesophagectomy and critical illness modulate neutrophil extracellular trap formation but not phagocytosis. GSK2862277 appears to cause an off-­target effect increasing neutrophil extracellular trap formation. GSK2862277 increases alveolar macrophage phagocytosis. Discussion Perioperative ARDS has decreased following oesophagectomy although it is harmful to patients who develop it. Oesophagectomy is no longer useful as a model of ARDS. Major surgery and critical illness effect neutrophil function, which may drive complications in these cohorts. Macrophage function was modulated by GSK2862277, suggesting it may have promise in future for preventing or treating ARDS and other post-­operative pulmonary complications."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Oesophagectomy as a model of the Acute Respiratory Distress Syndrome"]}]}],"canonical_facts":{"dc:contributor.sponsor":["other"],"dc:creator":["Howells, Phillip Alexander"],"dc:date":["2019-12-13"],"dc:date.issued":["2019-12"],"dc:description.abstract":["Acute Respiratory Distress Syndrome (ARDS) is a life­threatening illness which can follow major surgery, including oesophagectomy. This thesis aimed to confirm the importance of ARDS in this cohort and assess the effects of GSK2862277 Methods Analysis of previous oesophagectomy trials modelling ARDS sought differences between the studies and identified risk factors. The immunomodulatory effects of oesophagectomy and critical illness and novel therapeutic GSK2862277 on macrophage and neutrophil function were investigated using in vitro assays. Results Previous trials showed the harm to patients associated with ARDS, but falling ARDS rates more recently. Active smoking and pre-­operative dihydropyridine use were risk factors for ARDS. Oesophagectomy and critical illness modulate neutrophil extracellular trap formation but not phagocytosis. GSK2862277 appears to cause an off-­target effect increasing neutrophil extracellular trap formation. GSK2862277 increases alveolar macrophage phagocytosis. Discussion Perioperative ARDS has decreased following oesophagectomy although it is harmful to patients who develop it. Oesophagectomy is no longer useful as a model of ARDS. Major surgery and critical illness effect neutrophil function, which may drive complications in these cohorts. Macrophage function was modulated by GSK2862277, suggesting it may have promise in future for preventing or treating ARDS and other post-­operative pulmonary complications."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/9739/7/Howells2019MD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Inflammation and Ageing"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/9739/"],"dc:subject":["RD Surgery","RM Therapeutics. Pharmacology"],"dcterms:accessrights":["public"],"dc:title":["Oesophagectomy as a model of the Acute Respiratory Distress Syndrome"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_m_d"],"dc:type.qualificationname":["d_m_d"]},"updated_at":"2026-11-19T09:30:54Z"}